The present study provides additional evidence that polymorphisms of the HMOX1 and NQO1 genes are associated with high risk in metabolic disorders, such as blood systolic and diastolic pressure, hypertriglyceridemia, and low levels of HDL-c. The gene discussed is HMOX1; the disease is metabolic disease.